DEUTSCHE BANK AG\ - BIOANALYTICAL SYS INC ownership

BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 17 filers reported holding BIOANALYTICAL SYS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
DEUTSCHE BANK AG\ ownership history of BIOANALYTICAL SYS INC
ValueSharesWeighting
Q4 2019$17,000
+183.3%
3,447
+85.8%
0.00%
Q3 2019$6,000
+200.0%
1,855
+85.5%
0.00%
Q2 2019$2,000
-33.3%
1,000
-44.4%
0.00%
Q1 2019$3,000
-97.4%
1,800
-97.5%
0.00%
Q3 2018$114,000
-20.8%
71,368
-18.7%
0.00%
Q2 2018$144,000
+45.5%
87,800
+41.4%
0.00%
Q1 2018$99,000
-31.7%
62,094
+4.5%
0.00%
Q4 2017$145,000
+314.3%
59,400
+194.1%
0.00%
Q3 2017$35,00020,200
+11122.2%
0.00%
Q4 2014$0180
+17900.0%
0.00%
Q3 2013$010.00%
Other shareholders
BIOANALYTICAL SYS INC shareholders Q2 2018
NameSharesValueWeighting ↓
HealthInvest Partners AB 155,097$392,0000.22%
Kessler Investment Group, LLC 31,736$80,0000.14%
NORTH STAR ASSET MANAGEMENT INC 20,000$51,0000.01%
LADENBURG THALMANN FINANCIAL SERVICES INC. 3$00.00%
FEDERATED HERMES, INC. 1,429$4,0000.00%
UBS AG 2,210$6,0000.00%
DIMENSIONAL FUND ADVISORS LP 54,038$137,0000.00%
AMERICAN INTERNATIONAL GROUP, INC. 100$253,0000.00%
STATE STREET CORP 11,400$29,0000.00%
MORGAN STANLEY 14$00.00%
View complete list of BIOANALYTICAL SYS INC shareholders